ATE294168T1 - Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten - Google Patents

Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten

Info

Publication number
ATE294168T1
ATE294168T1 AT02779576T AT02779576T ATE294168T1 AT E294168 T1 ATE294168 T1 AT E294168T1 AT 02779576 T AT02779576 T AT 02779576T AT 02779576 T AT02779576 T AT 02779576T AT E294168 T1 ATE294168 T1 AT E294168T1
Authority
AT
Austria
Prior art keywords
trans
preparation
cyclohepta
dibenzo
tetrahydro
Prior art date
Application number
AT02779576T
Other languages
English (en)
Inventor
Yolande Lydia Lang
B P A M J Medaer
G J Hoornaert
Thierry Brossette
Frans J C Compernolle
Michel Joseph Mauric Guillaume
Hua Mao
Tomasz Kozlecki
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE294168T1 publication Critical patent/ATE294168T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02779576T 2001-12-07 2002-12-02 Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten ATE294168T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204961 2001-12-07
PCT/EP2002/013560 WO2003048146A1 (en) 2001-12-07 2002-12-02 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES

Publications (1)

Publication Number Publication Date
ATE294168T1 true ATE294168T1 (de) 2005-05-15

Family

ID=8181460

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02779576T ATE294168T1 (de) 2001-12-07 2002-12-02 Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten

Country Status (20)

Country Link
US (2) US6998494B2 (de)
EP (1) EP1456193B1 (de)
JP (1) JP4516752B2 (de)
KR (1) KR20050044329A (de)
CN (1) CN1293066C (de)
AT (1) ATE294168T1 (de)
AU (1) AU2002342926B2 (de)
BR (1) BR0214068A (de)
CA (1) CA2468038C (de)
DE (1) DE60203937T2 (de)
ES (1) ES2242076T3 (de)
HR (1) HRP20040490A2 (de)
HU (1) HUP0402152A3 (de)
IL (1) IL162349A0 (de)
MX (1) MXPA04005400A (de)
NO (1) NO20042884L (de)
NZ (1) NZ532806A (de)
PL (1) PL369585A1 (de)
WO (1) WO2003048146A1 (de)
ZA (1) ZA200404394B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE294168T1 (de) * 2001-12-07 2005-05-15 Janssen Pharmaceutica Nv Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
WO2005121113A1 (en) * 2004-06-14 2005-12-22 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives
CA2577305C (en) 2004-08-31 2013-12-17 Janssen Pharmaceutica N.V. Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid
RU2401257C2 (ru) 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
MX2007009092A (es) 2005-01-27 2007-09-12 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos heterociclicos como inhibidores de 5ht2 en el tratamiento de trastornos del sistema nervioso central.
CN101228154B (zh) 2005-06-17 2014-01-29 詹森药业有限公司 包含环状胺侧链的四环四氢呋喃衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69720709T2 (de) * 1996-04-12 2004-03-11 Janssen Pharmaceutica N.V. Substituierte tetracyclische tetrahydrofuranderivate
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
ATE294168T1 (de) * 2001-12-07 2005-05-15 Janssen Pharmaceutica Nv Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten
HUP0402325A2 (hu) * 2001-12-07 2005-02-28 Janssen Pharmaceutica N.V. Eljárás cisz-fuzionált 3,3a,8,12b-tetrahidro-2H-dibenzo [3,4:6,7] ciklohepta [1,2-b]furán-származékok előállítására

Also Published As

Publication number Publication date
US6998494B2 (en) 2006-02-14
HK1076461A1 (en) 2006-01-20
IL162349A0 (en) 2005-11-20
EP1456193A1 (de) 2004-09-15
US20050014820A1 (en) 2005-01-20
ES2242076T3 (es) 2005-11-01
DE60203937D1 (de) 2005-06-02
JP4516752B2 (ja) 2010-08-04
BR0214068A (pt) 2004-10-13
MXPA04005400A (es) 2004-10-11
CA2468038C (en) 2011-04-26
AU2002342926A1 (en) 2003-06-17
HUP0402152A3 (en) 2007-03-28
NO20042884L (no) 2004-07-07
WO2003048146A1 (en) 2003-06-12
US20050228043A1 (en) 2005-10-13
CA2468038A1 (en) 2003-06-12
HUP0402152A2 (hu) 2005-02-28
JP2005511691A (ja) 2005-04-28
CN1293066C (zh) 2007-01-03
PL369585A1 (en) 2005-05-02
AU2002342926B2 (en) 2009-02-26
NZ532806A (en) 2006-01-27
ZA200404394B (en) 2005-09-05
DE60203937T2 (de) 2006-05-11
KR20050044329A (ko) 2005-05-12
CN1602306A (zh) 2005-03-30
EP1456193B1 (de) 2005-04-27
HRP20040490A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
UA74391C2 (uk) Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти
HUP9701048A2 (hu) Új eljárás sildenafil előállítására és a felhasznált új köztitermékek
SE0102616D0 (sv) Novel compounds
AR031248A1 (es) Compuestos de ditosilato de quinazolina, composicion farmaceutica, metodo de tratamiento y uso en terapia y proceso para la preparacion de dichos compuestos
NZ522568A (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
DE60144392D1 (de) Antivirale mittel
DE60218048D1 (de) Thiophenverbindungen als arzneimittel
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
YU94103A (sh) Novi derivati sulfonske kiseline
EP1193256A8 (de) Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren
DE60203937D1 (de) Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten
NO20023405D0 (no) Fremgangsmåte for fremstilling av 5-Cyanoftalid
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
MXPA04005399A (es) Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano.
WO2001056992A3 (en) Dibenzo (b,f) azepine intermediates
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
ATE337827T1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
MXPA05008400A (es) Derivados de oxazolidinona n-sustituidos por un anillo triciclico, para su uso como agentes antibacterianos.
HRP20041208A2 (en) Pyrrolidine derivatives as oxytocin antagonists
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
AU6594900A (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
EE200300058A (et) Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1456193

Country of ref document: EP

REN Ceased due to non-payment of the annual fee